PARP inhibitors

What are PARP inhibitors?

Poly (ADP-ribose) polymerase inhibitors, also called PARP inhibitors, are targeted therapies that are used to treat cancer. PARP is a protein that has a role in cellular growth, regulation, and cell repair and it helps cancer cells repair themselves and survive. A PARP inhibitor stops cancer cells being repaired which causes the cells to die and reduces tumor growth.

How they work

DNA damage and mutation occurs naturally and can lead to cancer. If there is a small amount of DNA damage, the body can repair the DNA and the cell will survive. If there is too much damage, then the cell triggers its own death. The body repairs damaged DNA by using tumor suppressor genes (for example, the BRCA gene) and a protein called PARP. This system usually works well together. Any DNA damage is fixed by the tumor suppressor gene and by PARP, so the result is repaired DNA - meaning the cell survives, or, if there is too much damage to the DNA, the cell can't be repaired and it dies.

In cancers where the tumor suppressor gene is faulty, cancer cells are only repaired by PARP. The PARP repair is incomplete, which means the DNA is repaired to a point where it just has a small amount of damage and the cancer cells are able to able to grow and divide. If the PARP did not repair the DNA then the cancer cells would have too much damage and would trigger their own death. PARP inhibitors stops the DNA of cancer cells being repaired by PARP, and cell death is triggered. This inhibits the growth of the tumor.

What they treat

PARP inhibitors are used to treat cancers that have mistakes in their DNA repair genes (such as a BRCA mutation). Examples of cancers PARP inhibitors are used to treat include:

ovarian cancer
fallopian tube cancer
peritoneal cancer
breast cancer
prostate cancer.

List drug with PARP inhibitors

Drug Name
Lynparza Generic name: Olaparib
Niraparib Generic name: Niraparib
Olaparib Generic name: Olaparib
Rubraca Generic name: Rucaparib
Rucaparib Generic name: Rucaparib
Talazoparib Generic name: Talazoparib
Talzenna Generic name: Talazoparib
Zejula Generic name: Niraparib

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.